References
Adelman G, Rane SG, & Villa KF (2013). The cost burden of multiple
sclerosis in the United States: a systematic review of the literature. J
Med Econ 16: 639-647.
Ascherio A (2013). Environmental factors in multiple sclerosis. Expert
Rev Neurother 13: 3-9.
Baecher-Allan C, Kaskow BJ, & Weiner HL (2018). Multiple Sclerosis:
Mechanisms and Immunotherapy. Neuron 97: 742-768.
Bang JS, Oh DH, Choi HM, Sur BJ, Lim SJ, Kim JY, et al. (2009).
Anti-inflammatory and antiarthritic effects of piperine in human
interleukin 1beta-stimulated fibroblast-like synoviocytes and in rat
arthritis models. Arthritis Res Ther 11: R49.
Bar-Or A, Pachner A, Menguy-Vacheron F, Kaplan J, & Wiendl H (2014).
Teriflunomide and its mechanism of action in multiple sclerosis. Drugs
74: 659-674.
Bastaki M, Aubanel M, Bauter M, Cachet T, Demyttenaere J, Diop MM,
et al. (2018). Absence of adverse effects following administration of
piperine in the diet of Sprague-Dawley rats for 90 days. Food Chem
Toxicol 120: 213-221.
Comabella M, & Khoury SJ (2012). Immunopathogenesis of multiple
sclerosis. Clin Immunol 142: 2-8.
Dendrou CA, Fugger L, & Friese MA (2015a). Immunopathology of multiple
sclerosis. Nat Rev Immunol 15: 545-558.
Dendrou CA, Fugger L, & Friese MA (2015b). Immunopathology of multiple
sclerosis. Nature Reviews Immunology 15: 545-558.
Diao Y, Lu W, Jin H, Zhu J, Han L, Xu M, et al. (2012). Discovery
of diverse human dihydroorotate dehydrogenase inhibitors as
immunosuppressive agents by structure-based virtual screening. J Med
Chem 55: 8341-8349.
Dimitrova P, Skapenko A, Herrmann ML, Schleyerbach R, Kalden JR, &
Schulze-Koops H (2002). Restriction of de novo pyrimidine biosynthesis
inhibits Th1 cell activation and promotes Th2 cell differentiation. J
Immunol 169: 3392-3399.
Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, & Mills KH (2010). T
cells in multiple sclerosis and experimental autoimmune
encephalomyelitis. Clin Exp Immunol 162: 1-11.
Friese MA, & Fugger L (2005). Autoreactive CD8+ T cells in multiple
sclerosis: a new target for therapy? Brain 128: 1747-1763.
Garnock-Jones KP (2013). Teriflunomide: a review of its use in relapsing
multiple sclerosis. CNS Drugs 27: 1103-1123.
Goodnow CC (2007). Multistep pathogenesis of autoimmune disease. Cell
130: 25-35.
Gorgani L, Mohammadi M, Najafpour GD, & Nikzad M (2017). Piperine-The
Bioactive Compound of Black Pepper: From Isolation to Medicinal
Formulations. Compr Rev Food Sci F 16: 124-140.
Goverman J (2009). Autoimmune T cell responses in the central nervous
system. Nat Rev Rheumatol 9: 393.
Holland NJ, Schneider DM, Rapp R, & Kalb RC (2011). Meeting the needs
of people with primary progressive multiple sclerosis, their families,
and the health-care community. Int J MS Care 13: 65-74.
Jelcic I, Al NF, Wang J, Lentsch V, Planas R, Jelcic I, et al.(2018). Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells
in Multiple Sclerosis. Cell 175 (1): 85-100.e123.
Jennum P, Wanscher B, Frederiksen J, & Kjellberg J (2012). The
socioeconomic consequences of multiple sclerosis: a controlled national
study. Eur Neuropsychopharmacol 22: 36-43.
Lassmann H, & Bradl M (2017). Multiple sclerosis: experimental models
and reality. Acta Neuropathol 133: 223-244.
Liu H, Luo R, Chen X, Liu J, Bi Y, Zheng L, et al. (2013). Tissue
distribution profiles of three antiparkinsonian alkaloids from Piper
longum L. in rats determined by liquid chromatography-tandem mass
spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci
928: 78-82.
Liu S, Neidhardt EA, Grossman TH, Ocain T, & Clardy J (2000a).
Structures of human dihydroorotate dehydrogenase in complex with
antiproliferative agents. Structure 8: 25-33.
Liu SP, Neidhardt EA, Grossman TH, Ocain T, & Clardy J (2000b).
Structures of human dihydroorotate dehydrogenase in complex with
antiproliferative agents. Structure 8: 25-33.
Lo MC, Aulabaugh A, Jin GX, Cowling R, Bard J, Malamas M, et al.(2004). Evaluation of fluorescence-based thermal shift assays for hit
identification in drug discovery. Anal Biochem 332: 153-159.
Löffler M, Fairbanks LD, Zameitat E, Marinaki AM, & Simmonds HA (2005).
Pyrimidine pathways in health and disease. Trends Mol Med 11:430-437.
Löffler M, Jöckel J, & Schuster G (1997). Dihydroorotat-ubiquinone
oxidoreductase links mitochondria in the biosynthesis of pyrimidine
nucleotides. Mol Cell Biochem 174: 125-129.
Lu WQ, Yao X, Ouyang P, Dong NN, Wu D, Jiang XW, et al. (2017).
Drug Repurposing of Histone Deacetylase Inhibitors That Alleviate
Neutrophilic Inflammation in Acute Lung Injury and Idiopathic Pulmonary
Fibrosis via Inhibiting Leukotriene A4 Hydrolase and Blocking LTB4
Biosynthesis. J Med Chem 60: 1817-1828.
Manayi A, Nabavi SM, Setzer WN, & Jafari S (2017). Piperine as a
potential anti-cancer agent: a Review on Preclinical studies. Curr Med
Chem 25 (37): 4918-4928.
Mardiguian S, Serres S, Ladds E, Campbell SJ, Wilainam P, McFadyen
C, et al. (2013). Anti-IL-17A treatment reduces clinical score
and VCAM-1 expression detected by in vivo magnetic resonance imaging in
chronic relapsing EAE ABH mice. Am J Pathol 182: 2071-2081.
McLean JE, Neidhardt EA, Grossman TH, & Hedstrom L (2001). Multiple
inhibitor analysis of the brequinar and leflunomide binding sites on
human dihydroorotate dehydrogenase. Biochemistry 40: 2194-2200.
McNamara FN, Randall A, & Gunthorpe MJ (2005). Effects of piperine, the
pungent component of black pepper, at the human vanilloid receptor
(TRPV1). Br J Pharmacol 144: 781-790.
Micsonai A, Wien F, Kernya L, Lee YH, Goto Y, Refregiers M, et
al. (2015). Accurate secondary structure prediction and fold
recognition for circular dichroism spectroscopy. Proc Natl Acad Sci U S
A 112: E3095-3103.
Munier-Lehmann H, Vidalain PO, Tangy F, & Janin YL (2013). On
dihydroorotate dehydrogenases and their inhibitors and uses. J Med Chem
56: 3148-3167.
Najm FJ, Madhavan M, Zaremba A, Shick E, Karl RT, Factor DC, et
al. (2015). Drug-based modulation of endogenous stem cells promotes
functional remyelination in vivo. Nature 522: 216.
Quemeneur L, Gerland LM, Flacher M, Ffrench M, Revillard JP, &
Genestier L (2003). Differential control of cell cycle, proliferation,
and survival of primary T lymphocytes by purine and pyrimidine
nucleotides. J Immunol 170: 4986-4995.
Quijia CR, & Chorilli M (2020). Characteristics, Biological Properties
and Analytical Methods of Piperine: A Review. Crit Rev Anal Chem
50: 62-77.
Reich DS, Lucchinetti CF, & Calabresi PA (2018). Multiple Sclerosis. N
Engl J Med 378: 169-180.
Ridderstad Wollberg A, Ericsson-Dahlstrand A, Jureus A, Ekerot P, Simon
S, Nilsson M, et al. (2014). Pharmacological inhibition of the
chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat
model for multiple sclerosis. Proc Natl Acad Sci U S A 111:5409-5414.
Ruckemann K, Fairbanks LD, Carrey EA, Hawrylowicz CM, Richards DF,
Kirschbaum B, et al. (1998). Leflunomide inhibits pyrimidine de
novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.
J Biol Chem 273: 21682-21691.
Schmitz K, de Bruin N, Bishay P, Mannich J, Haussler A, Altmann C,
et al. (2014). R-flurbiprofen attenuates experimental autoimmune
encephalomyelitis in mice. EMBO Mol Med 6: 1398-1422.
Sykes DB, Kfoury YS, Mercier FE, Wawer MJ, Law JM, Haynes MK, et
al. (2016). Inhibition of Dihydroorotate Dehydrogenase Overcomes
Differentiation Blockade in Acute Myeloid Leukemia. Cell 167:171-186.e115.
T Hart BA, & Massacesi L (2009). Clinical, pathological, and
immunologic aspects of the multiple sclerosis model in common marmosets
(Callithrix jacchus). J Neuropathol Exp Neurol 68: 341-355.
Wang C, Wu C, Popescu DC, Zhu J, Macklin WB, Miller RH, et al.(2011). Longitudinal near-infrared imaging of myelination. J Neurosci
31: 2382.
Wanke F, Moos S, Croxford AL, Heinen AP, Graf S, Kalt B, et al.(2017). EBI2 Is Highly Expressed in Multiple Sclerosis Lesions and
Promotes Early CNS Migration of Encephalitogenic CD4 T Cells. Cell Rep
18: 1270-1284.
Wu D, Wang W, Chen W, Lian F, Lang L, Huang Y, et al. (2018).
Pharmacologic inhibition of dihydroorotate dehydrogenase induces
apoptosis and differentiation in acute myeloid leukemia cells.
Haematologica.
Xu X, Xu X, Liu P, Zhu ZY, Chen J, Fu HA, et al. (2015).
Structural Basis for Small Molecule NDB
(N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino)
Benzamide) as a Selective Antagonist of Farnesoid X Receptor alpha
(FXRalpha) in Stabilizing the Homodimerization of the Receptor. J Biol
Chem 290: 19888-19899.
Yin S, Kabashima T, Zhu Q, Shibata T, & Kai M (2017). Fluorescence
assay of dihydroorotate dehydrogenase that may become a cancer
biomarker. Sci Rep 7: 40670.
Zhao LL, Wang YQ, Cao DY, Chen TT, Wang Q, Li YL, et al. (2015).
Fragment-Based Drug Discovery of 2-Thiazolidinones as BRD4 Inhibitors:
2. Structure-Based Optimization. J Med Chem 58: 1281-1297.
Zozulya AL, & Wiendl H (2008). The role of regulatory T cells in
multiple sclerosis. Nat Clin Pract Neurol 4: 384-398.